Back
Astria Therapeutics 10K Form
Sell
19
ATXS
Astria Therapeutics
Last Price:
9.50
Seasonality Move:
-21.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATXS News And Ratings
See the #1 stock for the next 7 days that we like better than ATXS
ATXS Financial Statistics
Sales & Book Value
| Annual Sales: | $500K |
|---|---|
| Cash Flow: | $-30.25M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.60 |
| Price / Book: | 3.41 |
Profitability
| EPS (TTM): | -2.42000 |
|---|---|
| Net Income (TTM): | $-72.89M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Astria Therapeutics Earnings Forecast
Key Astria Therapeutics Financial Ratios
- The Interest Expense is -0.39% of Operating Income.
- Per Share Earnings over the last 11 years have been positive in 7 years.
Astria Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ATXS |
| Website: | astriatx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ATXS Technical Analysis vs Fundamental Analysis
Sell
19
Astria Therapeutics (ATXS)
is a Sell
Is Astria Therapeutics a Buy or a Sell?
-
Astria Therapeutics stock is rated a Sell
The current Astria Therapeutics [ATXS] share price is $9.18. The Score for ATXS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.